BrainStorm Cell Therapeutics Inc. Hosting A Conference Call With Clinical Trial Advisors In Israel, US And Brazil To Update Shareholders On Current Developments

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

NEW YORK & PETACH TIKVAH, Israel--(BUSINESS WIRE)--BrainStorm Cell Therapeutics (OTC.QB: BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases, today announced that it will hold a conference call on Thursday, January 30, 2014 at 8:45 a.m. Eastern Standard Time (EST), 15:45 Israel Standard Time (IST).

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC